Safe Notes in New Zealand: Legal Issues for Startups

A safe note can look like a founder-friendly shortcut when you need early funding fast. The trouble is that many New Zealand startups sign one without pinning down the valuation cap, ignore how the discount actually works, or rely on a template that was written for another country and another legal system. Those mistakes can become expensive later, especially when your first priced round arrives and everyone realises they understood the deal differently.

A SAFE is meant to be simpler than a traditional convertible note, but simple does not mean risk-free. Founders still need to think carefully about future share issues, investor rights, board approval, cap table impact, and whether the document actually fits New Zealand company law practice. This guide answers what a safe note is, what it means for New Zealand businesses, which legal issues to check before you sign, and the common traps that catch founders when the money is already on the table.

Overview

A safe note is a short-form investment instrument where an investor gives money now in exchange for a right to receive shares later, usually when a future equity financing happens. It is often used for early stage funding because it can defer valuation negotiations, but the legal and commercial terms still matter a great deal.

• Check whether the safe note is suitable for your company structure, cap table, and fundraising plans.
• Confirm how the valuation cap, discount, conversion mechanics, and any MFN clause actually operate.
• Review what happens on a liquidity event, dissolution, or if no priced round happens for a long time.
• Make sure board approvals, shareholder rights, and your constitution line up with the document.
• Watch for overseas template terms that do not sit neatly with New Zealand practice or your existing contracts.

What Safe Note Means For New Zealand Businesses

A safe note is usually treated as a contract giving the investor a future right to equity, not immediate shares and not standard debt in the way a loan would be.

SAFE originally stood for Simple Agreement for Future Equity. In startup terms, it lets a founder raise money before the business is ready for a full valuation discussion. The investor pays cash now, and the conversion into shares is triggered later under agreed conditions.

For New Zealand businesses, that usually means the document needs to work with your company constitution, your current shareholders' agreement if you have one, and the practical rules around issuing shares under the Companies Act 1993 and your internal approvals.

That matters because many founders use overseas forms. Those documents may be commercially familiar, but they often assume a different market standard, a different style of shareholder rights, and different securities law settings. A template can still be useful, but it should not be accepted as if it automatically fits a New Zealand company.

Why founders use a safe note

The main attraction is speed. A safe note can be quicker and cheaper to negotiate than a full equity round, particularly where the business has only early traction and the founders and investor do not want to spend weeks debating valuation.

It can also avoid setting a hard price for shares too early. That can help if the company expects stronger metrics, customers, or product validation in the next 6 to 12 months.

In practical terms, founders often reach for a safe note when:

• they need bridge funding before a larger seed round
• an angel investor wants to invest now but the lead round is not yet documented
• the company wants a simpler instrument than a convertible note with interest and maturity terms
• the parties want to postpone a detailed valuation discussion until more data exists

How it differs from a convertible note

A convertible note is commonly structured as debt that may convert into shares later. It often includes interest, a maturity date, and debt-style remedies if conversion does not happen as expected.

A safe note usually does not include interest and often has no maturity date. That sounds founder-friendly, but it can create uncertainty if the future financing never arrives or takes much longer than expected.

Founders sometimes assume a SAFE is always safer because the name says so. Legally, the better view is that it is simply a different instrument with a different risk profile. The commercial pressure points have not disappeared, they have just moved.

What investors usually focus on

Investors generally want a clear path to equity and confidence that they are being rewarded for taking an early risk. Before you sign, expect attention on:

• the valuation cap
• any discount to the next round price
• whether both cap and discount apply, and how the better outcome is chosen
• most favoured nation rights, if later SAFE investors get better terms
• treatment on an exit or company sale before conversion
• whether the investor gets information rights or other side rights

For founders, the big issue is dilution. A safe note can feel lightweight on signing day, then have a heavy effect on ownership once several instruments convert at once.

Legal Issues To Check Before You Sign

The safest approach is to treat a safe note as a serious financing contract, not a placeholder.

Before you sign a contract, you want to know exactly when the instrument converts, how many shares may be issued, what discretion the board has, and whether any existing investor documents restrict what you are promising. This is where founders often get caught, especially when a deal is agreed in principle over email and the formal wording is left until later.

1. Conversion mechanics

The conversion clause is the core of the deal. If it is vague, you can end up arguing about share numbers during your next fundraising, which is the worst possible time to have internal friction.

Check the trigger events carefully, such as:

• a qualified financing above a minimum amount
• any equity financing, whether or not it crosses a threshold
• a liquidity event, such as a sale of the company
• dissolution or winding up
• optional conversion approved by the company or investor

You also need to know the share class the investor receives on conversion. If the next round investors receive preference shares with special rights, the SAFE investor may convert into that class, or into another class set by the document. That can materially affect economics and control.

2. Valuation cap and discount

The valuation cap and discount decide how much of your company the investor may ultimately receive. Small drafting differences here can have a major cap table impact.

A valuation cap sets a maximum company valuation for conversion purposes. A discount gives the investor a reduced price compared with the next round investors. Some safe notes let the investor take whichever produces the better result. Others use only one mechanism.

Before you rely on a verbal promise, confirm in the signed document:

• how the company valuation is defined
• whether the cap is pre-money or post-money in effect
• how the conversion price is calculated
• whether the discount applies to the round price before or after adjustments
• how option pools or other convertible instruments are treated

This area causes a lot of founder surprise because two people can say “20 percent discount with a $5 million cap” and still mean different things once the formulas are written out.

3. Existing governance documents

Your safe note must fit with the rest of your legal paperwork. If it does not, you may create obligations you cannot lawfully or practically perform.

Review the interaction with:

• your company constitution
• any shareholders' agreement
• existing investor side letters
• board approval requirements
• pre-emptive rights on new share issues
• any reserved matters requiring shareholder consent

For example, your constitution or shareholders' agreement may restrict share issues or grant existing shareholders rights of first refusal. If the SAFE conversion would cut across those rights, the problem needs to be fixed before you sign, not during the next round.

4. Financial markets and offer issues

The legal treatment of fundraising can depend on who the investor is and how the offer is made. A startup should not assume every early-stage raise sits outside regulation.

In New Zealand, fundraising may raise Financial Markets Conduct Act questions, including whether an exclusion applies, such as offers to wholesale investors or other permitted categories. The right analysis depends on the facts, the investor profile, and how the raise is being conducted.

This article is not personal advice on securities law, but the practical point is simple: before you circulate a standard form to multiple investors, make sure the offer pathway has been checked.

5. Information rights and side promises

A short safe note sometimes becomes longer once investors ask for extra rights. That is not necessarily a problem, but each addition changes the deal.

Common extras include:

• financial reporting rights
• observer rights at board meetings
• pro rata rights in future rounds
• most favoured nation clauses
• consent rights on major decisions

These rights are often negotiated casually in emails or calls. Before you sign, gather them into the formal documents. Founders can get into trouble when they accept standard terms in one place, then make inconsistent side promises elsewhere.

6. Treatment on exit, sale, or shutdown

A safe note should say what happens if the company is sold before conversion or if the business fails.

Investors may be entitled to receive cash back, a multiple, the amount invested, or shares based on a conversion formula. The commercial outcome can be very different depending on the wording.

If your company is pursuing an acquisition strategy or has a realistic prospect of being bought before a priced round, these clauses deserve special attention. A founder might think the SAFE is only about the next funding round, but a sale event can bring the issue forward unexpectedly.

7. Cap table modelling

You should model the outcome before you sign, even if the raise is small.

That model should include:

• all existing shares and options
• all current safe notes or convertible instruments
• the proposed valuation cap and discount
• possible option pool increases in the next round
• different financing sizes and valuations

This is not just a finance exercise. It helps you understand whether the legal terms create an ownership outcome you are actually willing to live with.

Common Mistakes With Safe Note

The most common mistake is treating a safe note like a harmless interim document because the round is small and the investor is supportive.

That mindset leads to drafting shortcuts and assumptions that only become visible when you are under pressure in a future raise. Here are the errors we see most often in founder decision-making.

Using an overseas template without local review

A document built around United States startup norms may not match the way your New Zealand company is structured. Terms around share classes, board approvals, and investor rights can sit awkwardly with your constitution or with local market expectations.

The wording may also leave open practical questions about how the share issue will actually be implemented. The cost of checking this early through legal review is usually far less than the cost of fixing it mid-round.

Failing to define the next financing properly

If the trigger for conversion is poorly drafted, parties can disagree about whether a particular capital raise counts. That can happen where the business issues shares to a strategic investor, raises a smaller bridge round, or completes a mixed round with notes and equity.

Ambiguity here creates delay, and delay can make your lead investor nervous. Clear trigger language helps keep your fundraising moving.

Ignoring cumulative dilution

One safe note may look manageable. Several instruments signed over time can produce a very different picture.

Founders often focus on each investment individually and forget to look at all notes together. If multiple investors have caps, discounts, or MFN rights, your next round can become mathematically and legally messy.

Promising rights in side emails

An investor might ask for a quick confirmation that they will get pro rata rights, access to monthly financials, or a seat at important meetings. A founder may agree informally to keep momentum.

The problem is that informal promises can clash with the final documents or create expectations that later investors resist. Before you sign, pull all promises into a consistent set of written terms.

Not checking compatibility with existing investor documents

Earlier shareholders may already have consent rights or anti-dilution style protections. A new safe note can upset those arrangements, especially if it includes rights that were not offered before.

This is where founders often get caught between wanting to close the new money quickly and not wanting to reopen old investor negotiations. The better approach is to review the full document set upfront.

Assuming no maturity date means no urgency

A SAFE often has no maturity date, but that does not mean it can be ignored indefinitely. An instrument that sits unresolved for years can complicate due diligence, valuations, employee share plans, and exit discussions.

Potential investors and buyers usually want a clean understanding of all rights to future equity. Old unresolved notes can make the company look disorganised, even where nobody intended a dispute.

Overlooking founder alignment

Co-founders do not always see the trade-off the same way. One founder may be comfortable with heavy dilution in exchange for quick cash, while another is more concerned about long-term ownership and control.

Before you sign, make sure the founders and the board agree on the commercial objective, the dilution range, and the rights being offered. Misalignment inside the company is often more damaging than a difficult investor negotiation.

FAQs

Is a safe note debt?

Usually, no. A safe note is commonly structured as a contractual right to future equity rather than a standard loan. The exact legal effect depends on the document wording.

Can a New Zealand startup use a US SAFE form?

It can use one as a starting point, but it should not sign it blindly. The form needs to be checked against New Zealand company documents, local fundraising rules, and the intended commercial deal.

What is the biggest legal risk with a safe note?

The biggest risk is usually mismatch, between what the parties think they agreed and what the conversion wording actually does. That often shows up around valuation caps, discounts, and the share class issued on conversion.

Do safe note investors become shareholders immediately?

Usually not. In most cases, they become shareholders only when conversion happens under the agreed trigger event.

Can a safe note affect a later investment round?

Yes. It can affect valuation discussions, dilution, lead investor negotiations, due diligence, and the mechanics of issuing shares in the next round.

Key Takeaways

• A safe note can be a useful early-stage funding tool, but it is still a binding financing contract with real cap table consequences.
• New Zealand startups should check whether the document fits their constitution, shareholders' agreement, board approvals, and fundraising pathway.
• The most sensitive terms are usually the valuation cap, discount, conversion triggers, share class on conversion, and treatment on an exit or shutdown.
• Overseas templates, side promises, and poor cap table modelling are common sources of problems.
• Before you sign, make sure all founders understand the dilution outcome and that the paperwork matches the commercial deal.

If you want help with conversion terms, valuation cap drafting, investor rights, and constitution or shareholder agreement issues, you can reach us on 0800 002 184 or team@sprintlaw.co.nz for a free, no-obligations chat.